Navigation Links
Blue Cross Reverses Position on Autism After Federal Court Litigation Intensifies
Date:5/11/2009

DETROIT, May 11 /PRNewswire/ -- In federal court litigation, Johns v Blue Cross Blue Shield of Michigan, Case no. 08-cv-12272, Plaintiff Christopher Johns contends that Blue Cross illegally denied behavioral therapy to his autistic son, even though it was covered by his insurance policy. Plaintiff alleged that Blue Cross claimed that such therapy was "experimental" even though it was based on well-accepted scientific principles and was administered by such prestigious hospitals as Beaumont Hospital. In fact, during deposition testimony filed in federal court today, Blue Cross' corporate representative and Medical Director, Dr. Calmaze Dudley, conceded that applied behavioral therapy was supported by the prestigious American Academy of Pediatrics and candidly admitted that he would want such therapy for his own children, if they had autism:

    Q.  Based on your research and your investigation, if you had a child
        with autism, would you want them to receive ABA therapy?

    A.  Probably.

In a motion filed today, seeking to compel Blue Cross to produce further witnesses and documents, Plaintiff's attorney, Gerard Mantese, was confident that he will establish that Blue Cross' defense to the lawsuit is meritless and is contradicted by significant medical and scientific evidence of the effectiveness of behavioral therapy.

After one year of federal court proceedings in the Johns case, Blue Cross today announced that it was offering new coverage for the treatment of children with autism. Plaintiff's attorney, Gerard Mantese, stated: "We are pleased that the pressure of our lawsuit has caused Blue Cross to take a step toward doing the right thing for these families. In fact, Blue Cross first mentioned to us last year that it would be providing some treatment coverage to autistic children, after we began filing papers in our federal court lawsuit. We are confident that our litigation will cause Blue Cross to provide further relief to families who have been arbitrarily denied coverage for a scientifically established treatment that allows these children to achieve greater levels of self-sufficiency."

    For further information, please contact:

    Gerard Mantese
    Mantese and Rossman, P.C.
    1361 E. Big Beaver Road
    Troy, Michigan 48083
    248-457-9200 (office)
    248-515-6419 (cell)


'/>"/>
SOURCE Mantese and Rossman, P.C.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Blue Cross Blue Shield of Michigan Plans to Offer Customer Groups Ability to Purchase Coverage of Autism Treatment Programs that Provide Intensive Early Intervention
2. iCardiac's Highly Automated QT(sm) Technology Cross-Validated Against Results from Five Leading ECG Core Laboratories
3. Blue Cross and Blue Shield Funds Diabetes Education at Saints Mary and Elizabeth Medical Center
4. Anthem Blue Cross to Support Members and Communities Impacted by Santa Barbara Fires
5. SAMHSA Honors Goldie Hawn, Youth Across the Country in Celebration of National Childrens Mental Health Awareness Day
6. Northwestern Mutual Foundation Announces $500,000 Disaster Relief Donation for the American Red Cross
7. Fitness Industry Leaders Across the Nation Gather on Capitol Hill to Campaign for a Healthier America
8. Frost & Sullivan: Rising Public Awareness Promoting Acceptance of Infection Surveillance Systems Across Europe
9. Swine Flu Continues to Spread Across U.S.
10. Blue Cross Blue Shield of Michigan and Blue Care Network Launch Web Sites to Help Chrysler Members Easily Find Information on Their Health Care
11. GNC Helps to Raise Over $300,000 for National MS Society in First 30 Days of Ride Across America by Phil Keoghan of CBS The Amazing Race
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American ... function testing company, is now able to perform sophisticated lung assessments ... ndd Medical Technologies , Inc. Patients are no ...  Thanks to ndd,s EasyOne PRO ® , ARL patients like Jeanne ... needed testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
Breaking Medicine Technology: